Study Shows Nearly Half of CBD Users Are Able to Stop Taking Pharmaceuticals

Mar 19th 2019

Study Shows Nearly Half of CBD Users Are Able to Stop Taking Pharmaceuticals

The largest study to date regarding cannabidiol (CBD) has shown that many patients are finding such great relief from their ailments using CBD, that they are able to give up pharmaceutical prescriptions entirely.

The research was conducted by Brightfield Group and HelloMD. It covered 2,400 of HelloMD’s community. The pool consisted of 55 percent women. Statistically speaking, the results showed that men preferred THC-dominant products over CBD.

Dr. Perry Solomon, the chief medical officer of HelloMD, says the main reasons people use CBD are to treat insomnia, depression, anxiety, and joint pain.

“We are seeing an exponential rise in the interest of CBD products from our patient community—particularly among women,” Solomon told Forbes. “While we still have much to learn about CBD, we cannot ignore this one fact; the majority of those using CBD products today receive great benefit. This has the potential for far-reaching consequences.”

42 per cent of CBD users involved in the study told researchers that they had been able to give up prescription medications like Tylenol, ibuprofen, and stronger addictive prescription pain relievers thanks to CBD products.

A startling 80 per cent of the surveyed population said that they found CBD to be “very or extremely effective.”

Three percent claimed they did not notice any notable effect.

“This study is exciting because it shows there is potentially a huge barely-tapped market for CBD products that could improve the lives of many people,” said Bethany Gomez, who is the director of Brightfield Group. “With further research and public education, CBD could be an effective alternative treatment for many people, particularly at a time when our nation is in the midst of an opioid crisis.”